MedPath

Role of Positron Emission Tomography in Detecting Primary Tumor in Cases of Metastases of Unknown Origin

Recruiting
Conditions
Metastasis of Unknown Origin
Registration Number
NCT06086652
Lead Sponsor
Sohag University
Brief Summary

In most cases of malignancies, the site of origin of the cancer is clear at presentation or identified soon after. However, Metastatic cancer of unknown primary site (MUO) accounts for 3-5% of all malignant neoplasms, and it is defined as metastatic cancer from an unknown primary site, for which no original site can be detected even after performing all possible tests. Most common metastatic sites include the liver, lymph nodes, lungs, and bones.

18F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) allows whole-body tumor detection and has proven to be useful in patients with metastasis of unknown primary tumor.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Age > 18 years Patients with metastatic tumor. Primary site was not detected with other radiological examinations Both male and female.

Exclusion Criteria

Patients with known primary tumor Pregnancy. Age < 18 years.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary tumor for metastasis of unknown originone month

primary tumor for metastasis of unknown origin

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag university Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath